Efficacy of Immune Checkpoint Inhibitors Differs in Various Status of Carcinoma: A Study Based on 29 Cohorts with 3255 Participants

Researchers found that the presence of viral infection was evidently associated with improved outcomes in cancer patients undergoing immune checkpoint inhibitors, particularly in cases of HBV/HCV and HPV infections.